Karnataka DC Urges DCGI To Amend Drugs & Cosmetics Act

Karnataka drug controller, Dr BR Jagashetty has asked to amend Drugs & Cosmetics Act to restrict the movement of not-of-standard quality and defective packaging drugs in the state.

The controller calls to include a new Schedule, which will enable immediate recall of these kind of drugs by pharma companies.

As a part of the recommendations to be made to the Drugs Control General of India (DCGI) for an immediate implementation of the Good Distribution Practices (GDP) to check the prevalence of substandard drugs because of poor storage conditions and faulty packaging in the scores of pharmacy outlets across India, reported Pharmabiz.

Dr Jagashetty said: “In the interest of the consumers, the pharma manufacturers should act immediately because these drugs should no longer be sold when they are defective. There should be a clause in the Drugs and Cosmetics Act that if the recall is not made within a stipulated time frame, then it would become a punishable offence”

Dr Jagashetty claims that at least 60% of the problems are solved if there is recall of the drug and therefore, the Drugs &Cosmetics Act should make it compulsory.

Dr Jagashetty, added: “GDP should be part of Drugs & Cosmetic Act and a new schedule should be incorporated at the earliest. Manufacturers should follow the book of standards by Indian Pharmacopeia, British Pharmacopeia, and US Pharmacopeia.”